RBC Capital reiterated coverage on Tabula Rasa HealthCare with a new price target

11/8/21 9:28:50 AM ET

Business Services

Consumer Discretionary

RBC Capital reiterated coverage of Tabula Rasa HealthCare with a rating of Outperform and set a new price target of $23.00 from $70.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TRHC

Date	Price Target	Rating	Analyst
5/10/2023	$7.00 → $10.00	Market Perform → Outperform	SVB Securities
3/2/2022	$30.00 → $15.00	Buy	Benchmark
2/28/2022	$23.00 → $11.00	Market Perform	SVB Leerink
2/1/2022	$24.00 → $11.00	Outperform → Neutral	Robert W. Baird
2/1/2022	$24.00 → $11.00	Outperform → Neutral	Baird
12/2/2021	$13.00	Hold	Jefferies
11/8/2021	$70.00 → $23.00	Outperform	RBC Capital
11/8/2021	$40.00 → $23.00	Market Perform	SVB Leerink